These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1500724)
21. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307 [TBL] [Abstract][Full Text] [Related]
22. An anti-idiotype vaccine for AIDS based on the HIV receptor. Dalgleish AG Ann Ist Super Sanita; 1991; 27(1):27-31. PubMed ID: 1683525 [TBL] [Abstract][Full Text] [Related]
23. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes. Zaghouani H; Goldstein D; Shah H; Anderson S; Lacroix M; Dionne G; Kennedy R; Bona C Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5645-9. PubMed ID: 2062842 [TBL] [Abstract][Full Text] [Related]
24. Idiotype and anti-anti-idiotype antibodies to Neisseria gonorrhoeae lipooligosaccharides with bactericidal activity but no cross-reactivity with red blood cell antigens. Brossay L; Paradis G; Pépin A; Mourad W; Coté L; Hébert J J Immunol; 1993 Jul; 151(1):234-43. PubMed ID: 7686935 [TBL] [Abstract][Full Text] [Related]
25. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031 [TBL] [Abstract][Full Text] [Related]
26. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates. Pinter A; Honnen WJ; Racho ME; Tilley SA AIDS Res Hum Retroviruses; 1993 Oct; 9(10):985-96. PubMed ID: 7506556 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates. Nakamura GR; Byrn R; Rosenthal K; Porter JP; Hobbs MR; Riddle L; Eastman DJ; Dowbenko D; Gregory T; Fendly BM AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1875-85. PubMed ID: 1283308 [TBL] [Abstract][Full Text] [Related]
28. Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity. Shearer MH; Dalgleish AG; Chanh TC; Kennedy RC AIDS Res Hum Retroviruses; 2000 Jan; 16(1):77-86. PubMed ID: 10628819 [TBL] [Abstract][Full Text] [Related]
29. Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site. Burioni R; Mancini N; De Marco D; Clementi N; Perotti M; Nitti G; Sassi M; Canducci F; Shvela K; Bagnarelli P; Mascola JR; Clementi M PLoS One; 2008; 3(10):e3423. PubMed ID: 18923648 [TBL] [Abstract][Full Text] [Related]
30. Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals. Hariharan K; Nara PL; Shabazz LA; McCutchan JA; Kang CY AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1629-37. PubMed ID: 7888222 [TBL] [Abstract][Full Text] [Related]
31. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies. Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550 [TBL] [Abstract][Full Text] [Related]
32. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins. Neurath AR; Strick N; Li YY; Jiang S AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138 [TBL] [Abstract][Full Text] [Related]
33. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472 [TBL] [Abstract][Full Text] [Related]
34. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1. Keay S; Tacket CO; Murphy JR; Handwerger BS AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823 [TBL] [Abstract][Full Text] [Related]
35. Production of a human anti-CD4 monoclonal antibody with antiidiotype to anti-HIV type 1 glycoprotein 120. Karpatkin S; Nardi MA; Liu LX; Kouri YH; Borkowsky W AIDS Res Hum Retroviruses; 1995 Apr; 11(4):509-15. PubMed ID: 7632465 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. Burkly LC; Olson D; Shapiro R; Winkler G; Rosa JJ; Thomas DW; Williams C; Chisholm P J Immunol; 1992 Sep; 149(5):1779-87. PubMed ID: 1380539 [TBL] [Abstract][Full Text] [Related]
37. Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype. Attanasio R; Kennedy RC; Allan JS; Maino VC; Buck D; Kanda P Mol Immunol; 1990 Jun; 27(6):513-22. PubMed ID: 2116595 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals. Hariharan K; Nara PL; Caralli VM; Norton FL; Haigwood N; Kang CY J Virol; 1993 Feb; 67(2):953-60. PubMed ID: 7678311 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein. Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562 [TBL] [Abstract][Full Text] [Related]